Menu
GeneBe

rs192489011

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_020975.6(RET):c.200G>A(p.Arg67His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0004 in 1,613,870 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R67C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00059 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 5 hom. )

Consequence

RET
NM_020975.6 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:13O:1

Conservation

PhyloP100: 0.0800
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068158507).
BP6
Variant 10-43100585-G-A is Benign according to our data. Variant chr10-43100585-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 41839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-43100585-G-A is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RETNM_020975.6 linkuse as main transcriptc.200G>A p.Arg67His missense_variant 2/20 ENST00000355710.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RETENST00000355710.8 linkuse as main transcriptc.200G>A p.Arg67His missense_variant 2/205 NM_020975.6 P4P07949-1

Frequencies

GnomAD3 genomes
AF:
0.000585
AC:
89
AN:
152152
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0141
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00112
AC:
280
AN:
251082
Hom.:
0
AF XY:
0.00107
AC XY:
145
AN XY:
135820
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0123
Gnomad SAS exome
AF:
0.000359
Gnomad FIN exome
AF:
0.000694
Gnomad NFE exome
AF:
0.000194
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000380
AC:
556
AN:
1461600
Hom.:
5
Cov.:
64
AF XY:
0.000384
AC XY:
279
AN XY:
727084
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00763
Gnomad4 SAS exome
AF:
0.000487
Gnomad4 FIN exome
AF:
0.000941
Gnomad4 NFE exome
AF:
0.0000998
Gnomad4 OTH exome
AF:
0.000712
GnomAD4 genome
AF:
0.000591
AC:
90
AN:
152270
Hom.:
1
Cov.:
33
AF XY:
0.000604
AC XY:
45
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0143
Gnomad4 SAS
AF:
0.000623
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000417
Hom.:
0
Bravo
AF:
0.000525
ExAC
AF:
0.00101
AC:
123
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3Other:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 04, 2017- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 14, 2022- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 07, 2021- -
not provided, no classification providedreference populationITMISep 19, 2013- -
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJul 13, 2012- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsApr 12, 2017- -
Multiple endocrine neoplasia, type 2 Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthSep 29, 2022- -
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submittercurationSema4, Sema4Mar 08, 2021- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 07, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Pheochromocytoma Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 04, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Hirschsprung disease, susceptibility to, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 04, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Renal hypodysplasia/aplasia 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 04, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Multiple endocrine neoplasia type 2A Benign:1
Likely benign, criteria provided, single submitterclinical testingSt. Jude Molecular Pathology, St. Jude Children's Research HospitalNov 10, 2022- -
Multiple endocrine neoplasia Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 04, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.47
Cadd
Benign
9.5
Dann
Benign
0.77
DEOGEN2
Benign
0.37
T;.;.
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.60
T;T;T
MetaRNN
Benign
0.0068
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.91
L;.;L
MutationTaster
Benign
0.93
N;N
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.47
N;.;N
REVEL
Benign
0.13
Sift
Benign
0.61
T;.;T
Sift4G
Benign
0.58
T;T;T
Polyphen
0.0020
B;.;B
Vest4
0.028
MVP
0.47
MPC
0.93
ClinPred
0.011
T
GERP RS
-0.21
Varity_R
0.026
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs192489011; hg19: chr10-43596033; COSMIC: COSV60695179; COSMIC: COSV60695179; API